Aquestive Therapeutics Inc (AQST) USD0.001

Sell:$3.10Buy:$3.11$0.04 (1.14%)

NASDAQ:0.46%
Prices delayed by at least 15 minutes
Sell:$3.10
Buy:$3.11
Change:$0.04 (1.14%)
Deal now
Prices delayed by at least 15 minutes
Sell:$3.10
Buy:$3.11
Change:$0.04 (1.14%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. It is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. It has also developed a product pipeline focused on treating diseases of the central nervous system (CNS). Its PharmFilm technology is comprised of proprietary polymer compositions that serve as film formers to hold active pharmaceutical ingredients (APIs), and excipients in place. Its product portfolio and pipeline include Anaphylm, AQST-108, and Adrenaverse. Its CNS product candidate include Libervant. The Company’s Licensed commercial products and product candidates and other product includes Suboxone, Exservan, KYNMOBI, Zuplenz, Azstarys, Libervant, and Sympazan. Anaphylm is a non-device based, orally delivered epinephrine product candidate.

Key people

Daniel Barber
President, Chief Executive Officer, Director
A. Ernest Toth
Chief Financial Officer
Cassie Jung
Chief Operating Officer
Lori J. Braender
Chief Compliance Officer, Senior Vice President, General Counsel, Corporate Secretary
Sherry Korczynski
Senior Vice President of Sales and Marketing
Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
A. Mark Schobel
Chief Innovation and Technology Officer
Carl N. Kraus
Chief Medical Officer
Stephen Wargacki
Chief Science Officer
Gregory B. Brown
Independent Chairman of the Board
John S. Cochran
Independent Vice Chairman of the Board
Abigail L. Jenkins
Independent Director
Julie Krop
Independent Director
Timothy E. Morris
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US03843E1047
  • Market cap
    $263.51m
  • Employees
    135
  • Shares in issue
    91.18m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.